Ambalal Sarabhai Enterprises Ltd.
Fundamentals
- Market cap
- ₹245 cr
- P/E
- 13.76×
- ROE
- 3.52%
- Debt / equity
- 0.35
- 52-week range
- 23.12 — 38.85
Company snapshot
Ambalal Sarabhai Enterprises Ltd.
Pharmaceuticals
₹253 cr
P/E 14.23×
Latest quarter · Mar 2026
Sales₹65 cr
Net profit₹6 cr
Op. margin+8.7%
EPS₹0.85
Strength & growth
Debt / equity0.35×
Current ratio0.98×
Sales CAGR+40.0%
EPS CAGR−12.9%
The timeline — 2 notes on Ambalal Sarabhai Enterprises Ltd.
May 2026
- 21 May 26 · 7:52 PM IST Brief Brief · Earnings · Micro cap
Ambalal Sarabhai confirms already-disclosed FY26 results
The board formally approved financial statements and routine administrative items in a session that adds nothing to prior disclosures.
- 21 May 26 · 7:23 PM IST Brief Brief · Earnings · Micro cap
Ambalal Sarabhai net profit jumps to ₹17.80 cr on tax write-backs
A reversal of ₹6.65 crore in sales tax provisions helped the conglomerate lift bottom-line growth despite flat top-line performance.